HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Krasner Selected Research

Length of Stay

3/2000An update in the palliative management of malignant dysphagia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Krasner Research Topics

Disease

3Neoplasms (Cancer)
12/2003 - 03/2000
2Carcinoma (Carcinomatosis)
12/2003 - 01/2002
2Barrett Esophagus (Barrett's Esophagus)
12/2003 - 11/2001
1Metaplasia
12/2003
1AIDS-Related Complex (ARC)
01/2002
1Pain (Aches)
03/2000

Drug/Important Bio-Agent (IBA)

2Methylene Blue (Methylthioninium Chloride)FDA Link
12/2003 - 11/2001
1N- methyl- 1- (1,3- benzodioxol- 5- yl)- 2- butanamine (MBDB)IBA
12/2003
113(1)-(2'-(2-pyridyl)ethylamine) chlorin e6IBA
01/2002
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2002
1temoporfinIBA
01/2002
1ArgonIBA
01/2002
1XenonIBA
01/2002

Therapy/Procedure

2Photochemotherapy (Photodynamic Therapy)
04/2002 - 01/2002
1Dye Lasers
01/2002
1Length of Stay
03/2000
1Palliative Care (Palliative Therapy)
03/2000